COMMUNIQUÉS West-GlobeNewswire

Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
22/04/2024
Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaboration Following development candidate validation, Ipsen will assume responsibility for further [...]
Ipsen et Skyhawk Therapeutics annoncent la signature d'un accord de collaboration de recherche visant le ciblage d’ARN dans les maladies neurologiques rares
22/04/2024
Ipsen conclut un accord d'option pour les droits mondiaux exclusifs des candidats retenus dans le cadre de cette collaboration Une fois le candidat au développement validé, Ipsen sera responsable de la poursuite de son [...]
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering
22/04/2024
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva ® approved as one of first ustekinumab biosimilars in Europe EC approval based on robust development program confirming match to [...]
Ibogaine By David Dardashti' Investigates Correlation between Alcohol Addiction and Chemical Depression
22/04/2024
Ibogaine Clinic Aims to Create Sustainable Solutions to Treat Alcohol Addiction Miami, April 21, 2024 (GLOBE NEWSWIRE) -- The Ibogaine clinic by David Dardashti has announced its latest investigation into the [...]
Ibogaine By David Dardashti Offers New Treatment Procedure In Dedication Of Autism Awareness Month
22/04/2024
Ibogaine By David Dardashti Is Paving the Way For Autistic People With The Latest Treatment Procedure MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- To commemorate Autism Awareness Month, Ibogaine By David Dardashti is [...]
Ibogaine By David Dardashti Initiates Collaboration with Top Psychedelic Researchers
21/04/2024
Ibogaine By David Dardashti Seeks to Enhance Treatment Algorithms and Knowledge of Ibogaine MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a leading ibogaine provider in the world, is proud to [...]
Quantum Electrodynamics and Ibogaine: Enhancing Work Performance
21/04/2024
Ibogaine By David Dardashti claims improved treatment efficacy due to electromagnetic waves MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a leader in the field of ibogaine therapy, is [...]
Ibogaine By David Dardashti Encourages Patients to Practice Compassion
21/04/2024
Misty Huckabey explains how to Focus on Promoting Self-Love and Compassion MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, an organization that provides ibogaine-assisted addiction treatment, is [...]
Ibogaine By David Dardashti Offers Expanded Treatment Options
21/04/2024
Ibogaine By David Dardashti Enhances Treatment with Holistic Therapy Services MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce an expanded treatment program providing greater [...]
Ibogaine By David Dardashti Takes Pride in Participating in Sexual Awareness Month
21/04/2024
Clinic Works to Create New Solutions to Combat Sexual Assault MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is a specialized clinic that focuses on treating addiction, particularly in instances [...]
Ibogaine By David Dardashti Announces New Algorithm For Alcohol Addiction
21/04/2024
Revolutionary Method to Combat Alcoholism and Restore Quality of Life MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a prominent provider of natural and holistic remedies for substance abuse, has [...]
Ibogaine by David Dardashti Introduces New Algorithm for Methadone Addiction
21/04/2024
Algorithm Varies Slightly from Suboxone and Focuses on Continuously Dosed Ibogaine Treatment MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- The novel algorithm signifies a notable deviation from Suboxone, a frequently [...]
Ibogaine By David Dardashti Introduces New Algorithm for Depression Treatment
21/04/2024
A Revolutionary Advancement in Depression Treatments MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- In recent years, there has been a surge in clinical studies exploring the use of Ibogaine in treating depression. David [...]
Remedium Healthcare Products Launches NuVeria Labs' Groundbreaking Sacral Silicone Dressing, Now Available for Purchase on Amazon Prime
20/04/2024
Remedium Healthcare Products announces the launch of NuVeria Labs' Sacral Silicone Dressing on Amazon, setting a new standard in accessible, advanced wound care NORTHBROOK, Ill., April 19, 2024 (GLOBE NEWSWIRE) -- [...]
Vaxxinity Issues Shareholder Letter
20/04/2024
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced [...]
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
19/04/2024
FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
19/04/2024
SAN CARLOS, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel [...]
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
19/04/2024
SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the [...]
StateHouse Provides an Update on Application for Management Cease Trade Order
19/04/2024
SAN DIEGO and TORONTO, April 19, 2024 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc . (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQB: STHZF), a California-focused, vertically integrated cannabis company, today [...]

Pages